Dark

MLAB
Mesa Laboratories Inc
stock NASDAQ

At Close

Jul 14, 2025 3:59:55 PM EDT

82.63USD-4.386%(-3.79)234,073

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-86.42)0

After-hours

Jul 14, 2025 4:00:30 PM EDT

82.86USD+0.272%(+0.23)655

OverviewHistoricalExchangesShortsNews

Jan 6, 2022

03:00PM EST Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2022, to shareholders of record at the close of business on February 28, 2022. GlobeNewswire Inc

Nov 8, 2021

10:12AM EST How Good Are Mesa Laboratories's Earnings? | Return On Invested Capital Benzinga

Nov 4, 2021

08:23AM EDT Mesa Laboratories Q2 Adj. EPS $1.87, Sales $35.84M Up From $31.86M YoY Benzinga

08:00AM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (2Q22) and six months ended September 30, 2021. GlobeNewswire Inc

Oct 29, 2021

08:00AM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Shiraz Ladiwala to its Board of Directors, effective October 28, 2021. Shiraz previously worked in leadership roles at Thermo Fisher Scientific and retired on August 31, 2021. GlobeNewswire Inc

Oct 20, 2021

12:06PM EDT Mesa Labs Closes Acquisition of Agena Bioscience GlobeNewswire Inc

Oct 1, 2021

03:00PM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2021, to shareholders of record at the close of business on November 30, 2021. GlobeNewswire Inc

Sep 14, 2021

08:07AM EDT Mesa Laboratories, Inc. (MLAB) announced Tuesday that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments. RTTNews

08:00AM EDT Mesa Labs Agrees To Acquire Agena Bioscience For $300 Mln Cash RTTNews

07:50AM EDT The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout Benzinga

07:06AM EDT Mesa Labs Announces Agreement To Acquire Agena Bioscience, Inc. For Cash Purchase Price Of $300M Benzinga

07:00AM EDT Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc. GlobeNewswire Inc

Sep 8, 2021

10:36AM EDT Looking Into Mesa Laboratories's Return On Capital Employed Benzinga

Aug 5, 2021

08:38AM EDT Mesa Laboratories Q1 EPS $1.72 Up From $1.67 YoY, Sales $34.92M Up From $29.94M YoY Benzinga

Jul 7, 2021

11:16AM EDT Looking Into Mesa Laboratories's Return On Capital Employed Benzinga

Jul 6, 2021

07:19PM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2021, to shareholders of record at the close of business on August 31, 2021. GlobeNewswire Inc

Jun 1, 2021

09:56AM EDT Mesa Laboratories: Q4 Earnings Insights Benzinga

08:18AM EDT Mesa Laboratories Q4 Revenues Increase 11% To $37,964 RTTNews

08:18AM EDT Mesa Laboratories Q4 EPS $1.98 Benzinga

08:00AM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (4Q21) and full year ended March 31, 2021 (FY21). GlobeNewswire Inc

Apr 5, 2021

05:00PM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2021, to shareholders of record at the close of business on May 31, 2021. GlobeNewswire Inc

Feb 3, 2021

08:09AM EST Mesa Laboratories Q3 EPS $1.46 Up From $0.65 YoY, Sales $34.17M Up From $31.66M YoY Benzinga

08:00AM EST Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (3Q21) and nine months ended December 31, 2020. GlobeNewswire Inc

Jan 5, 2021

05:00PM EST Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2021, to shareholders of record at the close of business on February 26, 2021. GlobeNewswire Inc

Jan 4, 2021

10:04AM EST Benzinga's Top Upgrades, Downgrades For January 4, 2021 Benzinga

08:25AM EST Evercore ISI Group Downgrades Mesa Laboratories to In-Line, Announces $300 Price Target Benzinga

Nov 5, 2020

08:08AM EST Mesa Laboratories Q2 EPS $1.91 Up From $1.74 YoY, Sales $31.86M Up From $25.54M YoY Benzinga

Oct 2, 2020

05:53AM EDT JP Morgan Initiates Coverage On Mesa Laboratories with Neutral Rating, Announces Price Target of $260 Benzinga

Oct 1, 2020

04:00PM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, Mesa Labs or the Company) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2020, to shareholders of record at the close of business on November 30, 2020. GlobeNewswire Inc

Aug 6, 2020

09:32AM EDT Mesa Laboratories Earlier Reported Q1 EPS $0.22 Down From $1.13 YoY, Sales $29.94M Up From $26.29M YoY Benzinga

08:00AM EDT Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (1Q21). GlobeNewswire Inc

document.getElementById("kslBtG").onerror = function(){this.style.display='none';}; .dark-mode .vSJSng{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .vSJSng{ color: #333333; background-color: white; border: 2px solid #333333; }MLABMesa Laboratories Incstock NASDAQ

MLAB
Mesa Laboratories Inc
stock NASDAQ